Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 279 recruiting now early-phase tilt #6 of 28,963 conditions

Cancer: early-phase trial registry

279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #6 of 28,963 conditions by registered trial count.

621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count

Cancer: 621 US clinical trials tracked, 279 recruiting.

Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.

Open enrollment, early-phase tilt

Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.

279
recruiting participants now
45%
of trials open to enrollment
31
in Phase 3-4 (later-stage)
31
top sponsor: M.D. Anderson Cancer Center

Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Cancer is recruiting above its size-band peers.

    279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Cancer trials is spread across many organizations.

    M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cancer enrolment sits around 108 participants.

    Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.

  4. Cancer research is mostly interventional.

    462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1116Phase 248Phase 327Phase 44

Open and recent trials

621 total, page 1 of 13

RECRUITING 200,000 participants

Connect for Cancer Prevention Study (Connect)

National Cancer Institute (NCI)

NCT04609072

RECRUITING 100,000 participants

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

Hercules

NCT06212479

RECRUITING 100,000 participants

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

National Minority Quality Forum

NCT07461493

RECRUITING 100,000 participants

Caris Biorepository Research Protocol

Caris Science

NCT01499394

RECRUITING NA 50,000 participants

Galleri® in the Medicare Population.

GRAIL

NCT05673018

RECRUITING 50,000 participants

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio

NCT03452774

RECRUITING 50,000 participants

Childhood Cancer Survivor Study

St. Jude Children's Research Hospital

NCT01120353

RECRUITING 47,500 participants

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

New Mexico Cancer Research Alliance

NCT03977402

RECRUITING 25,000 participants

Falcon Real World Evidence Registry

Exact Sciences Corporation

NCT06589310

RECRUITING 25,000 participants

Avera Cancer Sequencing and Analytics Protocol (ASAP)

Avera McKennan Hospital & University Health Center

NCT05142033

RECRUITING 20,000 participants

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

N-Power Medicine

NCT06877884

RECRUITING 16,000 participants

Food and Microbiome Longitudinal Investigation (FAMiLI)

NYU Langone Health

NCT03293758

RECRUITING 15,000 participants

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Cancer Support Community, Research and Training Institute, Philadelphia

NCT02333604

RECRUITING 15,000 participants

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

MiraKind

NCT02253251

RECRUITING 10,000 participants

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation

University of Texas Southwestern Medical Center

NCT03617237

RECRUITING 10,000 participants

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

St. Jude Children's Research Hospital

NCT00760656

RECRUITING 10,000 participants

Collection and Distribution of Biospecimens for Novel Research Uses

iSpecimen

NCT03848962

RECRUITING 10,000 participants

Umbrella Study for Analysis of Data Related to Patients With Cancer

Tempus AI

NCT06018753

RECRUITING 10,000 participants

Arizona Cancer Center Biospecimen Repository

University of Arizona

NCT00896935

RECRUITING 10,000 participants

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

Sameem M. Abedin, MD

NCT05802069

RECRUITING 10,000 participants

The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

Baylor Research Institute

NCT05371756

RECRUITING 10,000 participants

Study of Personalized Cancer Therapy to Determine Response and Toxicity

Shu Mei Kato

NCT02478931

RECRUITING 10,000 participants

Inherited CAncer REgistry

Vanderbilt-Ingram Cancer Center

NCT03231891

RECRUITING NA 7,649 participants

Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

H. Lee Moffitt Cancer Center and Research Institute

NCT06560398

RECRUITING NA 7,500 participants

Evaluating the Implementation and Impact of Navigator-delivered ePRO System

University of Alabama at Birmingham

NCT04809740

RECRUITING NA 6,516 participants

My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life

Northwestern University

NCT05369429

RECRUITING 5,000 participants

Effects of Oncological Treatment During Pregnancy on Mother and Child

University Hospital, Gasthuisberg

NCT00330447

RECRUITING 5,000 participants

A Crowd Sourcing Platform for Patients With Cancer

All4Cure

NCT03530826

RECRUITING 5,000 participants

Morehouse Total Cancer Care Protocol

Morehouse School of Medicine

NCT04804878

RECRUITING 5,000 participants

Vincere Biobank Research Protocol

Vincere Cancer Center

NCT05954299

RECRUITING NA 3,000 participants

Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

London School of Economics and Political Science

NCT06997185

RECRUITING 3,000 participants

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Texas A&M University

NCT06726590

RECRUITING NA 2,996 participants

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Stanford University

NCT05297734

RECRUITING Phase 3 2,800 participants

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

University of California, San Diego

NCT05443737

RECRUITING 2,500 participants

TREC@TAMU Cancer Prevention Registry and Repository

Texas A&M University

NCT06826014

RECRUITING 2,400 participants

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

Exai Bio

NCT05833360

RECRUITING 2,000 participants

A Natural History Study of Metabolic Sizing in Health and Disease

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT05398783

RECRUITING 2,000 participants

Compliant Analysis of Patient Samples and Data

Sequenom

NCT04364503

RECRUITING 2,000 participants

Occupational Exposures Among Firefighters

Vincere Cancer Center

NCT06173843

RECRUITING 2,000 participants

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Oxford Biodynamics

NCT06635954

RECRUITING 2,000 participants

Phase I Human Analytics (HALO) Study

HALO Diagnostics

NCT05423860

RECRUITING 2,000 participants

UNC Metastatic Cancer Radiation Therapy Registry

UNC Lineberger Comprehensive Cancer Center

NCT06306924

RECRUITING 2,000 participants

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Elephas

NCT07327489

RECRUITING 2,000 participants

Multi-Cancer Early Detection (MCED) of Firefighters

Vincere Cancer Center

NCT05780957

RECRUITING 1,650 participants

Prospective Study to Assess a Diagnostic Aid for Cancer

Harbinger Health

NCT07046260

RECRUITING 1,500 participants

Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer

Memorial Sloan Kettering Cancer Center

NCT03922893

RECRUITING 1,500 participants

Immune Profiling for Cancer Immunotherapy Response

Dartmouth-Hitchcock Medical Center

NCT06116032

RECRUITING NA 1,500 participants

Testicular Tissue Cryopreservation for Fertility Preservation

University of Pittsburgh

NCT02972801

RECRUITING Phase 2 1,500 participants

Pan Tumor Rollover Study

Bristol-Myers Squibb

NCT03899155

RECRUITING NA 1,300 participants

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

University of Chicago

NCT05166694

Page 1 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 116
Phase 2 48
Phase 3 27
Phase 4 4

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Cancer right now

279 recruiting of 621 indexed (45% open).

Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).

Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Cancer?

PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Cancer?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.